• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Qorvo Inc.

    6/26/25 4:17:46 PM ET
    $QRVO
    Semiconductors
    Technology
    Get the next $QRVO alert in real time by email
    DEFA14A 1 d799121ddefa14a.htm DEFA14A DEFA14A
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 14A

    INFORMATION REQUIRED IN PROXY STATEMENT

    SCHEDULE 14A INFORMATION

    Proxy Statement Pursuant to Section 14(a)

    of the Securities Exchange Act of 1934

    Filed by the Registrant ☒

    Filed by a Party other than the Registrant ❑

    Check the appropriate box:

     

    ❑   Preliminary Proxy Statement
    ❑   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    ❑   Definitive Proxy Statement
    ☒   Definitive Additional Materials
    ❑   Soliciting Material Pursuant to §240.14a-12
    Qorvo, Inc.
    (Name of Registrant as Specified In Its Charter)
    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)
    Payment of Filing Fee (Check all boxes that apply):
    ☒   No fee required.
    ❑   Fee paid previously with preliminary materials.
    ❑   Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

     
     


    LOGO

    Your Vote Counts QORVO, INC. 2025 Annual Meeting Vote by August 12, 2025 11:59 PM EDT QORVO, INC. C/O BROADRIDGE PO BOX 1342 BRENTWOOD, NY 11717 V76095-P35564 You invested in QORVO, INC. and it’s time to vote You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on August 13, 2025. Get informed before you vote View the Notice and Proxy Statement and Annual Report online OR you can receive a free paper or email copy of the material(s) by requesting prior to July 30, 2025. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. For complete information and to vote, visit www.ProxyVote.com Control # Smartphone users Vote in Person at the Meeting* Point your camera here and August 13, 2025 8:00 A.M. Central Time vote without entering a control number Location: The Renaissance Dallas at Plano Legacy West Hotel 6007 Legacy Drive Plano, TX 75024 *Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.


    LOGO

    Vote at www.ProxyVote.com THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. Board Voting Items Recommends 1. Election of Directors Nominees: 1a. Robert A. Bruggeworth For 1b. Judy Bruner For 1c. Richard L. Clemmer For 1d. Peter A. Feld For 1e. John R. Harding For 1f. Christopher R. Koopmans For 1g. Alan S. Lowe For 1h. Roderick D. Nelson For 1i. Dr. Walden C. Rhines For 1j. Susan L. Spradley For 2. To approve, on an advisory basis, the compensation of our Named Executive Officers (as disclosed in the For proxy statement). 3. To approve the Qorvo, Inc. Amended and Restated 2022 Stock Incentive Plan. For 4. To approve the Qorvo, Inc. Amended and Restated 2007 Employee Stock Purchase Plan. For 5. To ratify the appointment of Ernst & Young LLP as Qorvo Inc.’s independent registered public accounting firm for the For fiscal year ending March 28, 2026. 6. To consider a stockholder proposal relating to special meetings of Qorvo, Inc.’s stockholders, if properly presented. Against Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. V76096-P35564

    Get the next $QRVO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $QRVO

    DatePrice TargetRatingAnalyst
    4/30/2025$95.00Hold → Buy
    The Benchmark Company
    4/30/2025$90.00 → $80.00Hold
    TD Cowen
    1/27/2025$85.00 → $110.00Neutral → Overweight
    Piper Sandler
    1/21/2025$90.00 → $106.00Equal-Weight → Overweight
    Morgan Stanley
    11/12/2024$73.00Hold
    Loop Capital
    10/30/2024Buy → Hold
    The Benchmark Company
    10/30/2024$125.00 → $85.00Hold
    TD Cowen
    10/30/2024Outperform → Mkt Perform
    Raymond James
    More analyst ratings

    $QRVO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SVP, Advanced Cellular Stewart Frank P. covered exercise/tax liability with 2,378 shares and was granted 13,490 shares, increasing direct ownership by 44% to 36,240 units (SEC Form 4)

      4 - Qorvo, Inc. (0001604778) (Issuer)

      5/19/25 4:44:19 PM ET
      $QRVO
      Semiconductors
      Technology
    • VP and Corporate Controller Harrison Gina covered exercise/tax liability with 850 shares and was granted 4,214 shares, increasing direct ownership by 16% to 24,884 units (SEC Form 4)

      4 - Qorvo, Inc. (0001604778) (Issuer)

      5/19/25 4:43:02 PM ET
      $QRVO
      Semiconductors
      Technology
    • SVP, Global Operations Fego Paul J covered exercise/tax liability with 5,263 shares and was granted 21,920 shares, increasing direct ownership by 41% to 57,701 units (SEC Form 4)

      4 - Qorvo, Inc. (0001604778) (Issuer)

      5/19/25 4:42:25 PM ET
      $QRVO
      Semiconductors
      Technology